These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28945172)

  • 1. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different assessments of immunohistochemically stained Ki-67 and hTERT in glioblastoma multiforme yield variable results: a study with reference to survival prognosis.
    Persson A; Englund E
    Clin Neuropathol; 2008; 27(4):224-33. PubMed ID: 18666438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Jagged1 expression is associated with poor outcome in primary glioblastoma.
    Qiu XX; Wang CH; You N; Chen BJ; Wang XF; Chen YP; Lin ZX
    Med Oncol; 2015 Jan; 32(1):341. PubMed ID: 25424769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
    Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
    Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
    Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
    Mellai M; Annovazzi L; Bisogno I; Corona C; Crociara P; Iulini B; Cassoni P; Casalone C; Boldorini R; Schiffer D
    Cells; 2020 Jun; 9(6):. PubMed ID: 32599896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
    Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R
    BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
    Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
    Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
    Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
    Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the prognostic value of CD44 in glioblastoma multiforme.
    Wei KC; Huang CY; Chen PY; Feng LY; Wu TW; Chen SM; Tsai HC; Lu YJ; Tsang NM; Tseng CK; Pai PC; Shin JW
    Anticancer Res; 2010 Jan; 30(1):253-9. PubMed ID: 20150644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.
    Chen L; Liu YC; Zheng YY; Xu J; Zhang Y; Liu WL; Li ZY; Huang GD; Li WP
    Phytother Res; 2019 Jun; 33(6):1736-1747. PubMed ID: 31006910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of stem cell markers CD44 and nestin in glioblastomas: Evaluation of their prognostic significance.
    Guadagno E; Borrelli G; Califano M; Calì G; Solari D; Del Basso De Caro M
    Pathol Res Pract; 2016 Sep; 212(9):825-32. PubMed ID: 27450656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
    Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
    Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.
    Chen Y; Wang H; Tan C; Yan Y; Shen J; Huang Q; Xu T; Lin J; Chen J
    Folia Neuropathol; 2018; 56(1):30-38. PubMed ID: 29663738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 labeling index in glioblastoma; does it really matter?
    Alkhaibary A; Alassiri AH; AlSufiani F; Alharbi MA
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):82-88. PubMed ID: 30552865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.